Increase of pseudoprogression and other treatment related effects in low-grade glioma patients treated with proton radiation and temozolomide.
Michael DworkinWilliam MehanAndrzej NiemierkoSophia C KamranNayan LambaJorg DietrichMaria Martinez-LageKevin S OhTracy T BatchelorPatrick Y WenJay S LoefflerHelen A ShihPublished in: Journal of neuro-oncology (2018)
TMZ use, when added to PRT, was associated with increased PsP in patients with LGG; however, patients with PsP tended to achieve longer survival.